Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 14, 2021

SYNTAX II PCI Improves Upon Previous Outcomes

European Heart Journal


Additional Info

Disclosure statements are available on the authors' profiles:

European Heart Journal
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study
Eur Heart J 2021 Oct 07;[EPub Ahead of Print], AP Banning, P Serruys, GL De Maria, N Ryan, S Walsh, N Gonzalo, R Jan van Geuns, Y Onuma, M Sabate, J Davies, M Lesiak, R Moreno, I Cruz-Gonzalez, SP Hoole, JJ Piek, C Appleby, F Fath-Ordoubadi, A Zaman, NM Van Mieghem, N Uren, J Zueco, P Buszman, A Iniguez, J Goicolea, D Hildick-Smith, A Ochala, D Dudek, T de Vries, D Taggart, V Farooq, E Spitzer, J Tijssen, J Escaned

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading